• Home
  • Technology
    • Gelrin Technology and Status
    • Patents
    • Market, Competition and Opportunity
    • Videos
  • Investors
  • Contact Us
Regentis Biomaterials Logo
Regentis Biomaterials Logo
  • HOME
  • TECHNOLOGY
    • Gelrin Technology and Status
    • Patents
    • Market, Competition and Opportunity
    • Videos
  • INVESTORS
  • CONTACT US

Investor Relations

Analyst Coverage

☰  IR MENU
  • Overview
  • Press Releases
  • SEC Filings
  • Stock Info
    • Stock Chart
    • Historical Stock Quote
    • Analyst Coverage
  • Events & Presentations
  • Governance
    • Scientific Advisory Board
    • Management
    • Board of Directors
    • Committee Composition
    • Documents
  • Resources
    • Contact IR
    • Email Alerts
  • Overview
  • Press Releases
  • SEC Filings
  • Stock Info
    • Stock Chart
    • Historical Stock Quote
    • Analyst Coverage
  • Events & Presentations
  • Governance
    • Scientific Advisory Board
    • Management
    • Board of Directors
    • Committee Composition
    • Documents
  • Resources
    • Contact IR
    • Email Alerts
Firm Analyst
Think Equity Ashok Kumar, Ph.D., CFA

Regentis is followed by the analysts above. Please note that any opinions, estimates or forecasts regarding Regentis's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Regentis or its management.

Security holders may request a hard copy of Regentis’s Annual Report, including its complete audited consolidated financial statements, free of charge, to its shareholders upon request to Regentis Investor Relations at 60 Medinat Hayehudim Street, 4676652, Israel or by phone at +972 (9) 960-1917. 

© 2026 Regentis Biomaterials. All Rights Reserved
|
Terms of Use
|
Privacy Policy
|
Accessibility Declaration
|
Sitemap
|
Powevered by ACCESS Newswire
Share by: